查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1667815

2025 年全球免疫诊断市场报告

Immunodiagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年免疫诊断药物市场规模将强劲成长。到 2029 年，这一数字将成长至 331.4 亿美元，复合年增长率为 7.8%。预测期内的成长可归因于流行病的防范和应对、个人化医疗和生物标誌物的发现、新兴市场不断增长的医疗保健基础设施、与实验室资讯系统的整合以及慢性病负担的增加。预测期内的关键趋势包括多重技术、就地检验（POCT）、生物标记发现和个人化医疗、数位免疫诊断的兴起以及向液态切片的转变。

预计未来几年感染疾病的流行将推动免疫诊断市场的成长。感染疾病是由病毒、细菌、真菌或寄生虫等病原体引起的、可在人与人之间传播的疾病。免疫诊断试验用于检测血液样本中是否有病毒。例如，2024年3月，美国政府机构疾病管制与预防中心（CDC）报告称，结核病病例数将从2022年的8320例增至2023年的9615例，增加1295例。因此，感染疾病的日益普及预计将大幅推动免疫诊断药物市场的发展。

医疗保健支出的增加预计将推动免疫诊断市场的未来成长。医疗保健支出是指医疗保健总支出，包括在特定卫生系统或经济体中花在医疗保健相关商品和服务上的所有资金。这笔支出对于加速免疫诊断解决方案的开发和利用至关重要。例如，总部位于加拿大的非营利组织加拿大卫生资讯研究所在2023年11月预测，2023年医疗保健总支出将达到3,440亿美元，与前一年同期比较小幅增加2.8%。因此，医疗保健支出的增加正在推动免疫诊断市场的扩张。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第 4 章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球免疫诊断PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球免疫诊断市场：成长率分析
  • 全球免疫诊断市场表现：规模与成长，2019 年至 2024 年
  • 全球免疫诊断市场预测：规模与成长，2024-2029 年，2034 年预测
  • 全球免疫诊断总目标市场 (TAM)

第六章 市场细分

  • 全球免疫诊断市场：依产品、效能和预测，2019-2024 年、2024-2029 年、2034 年
  • 试剂和耗材
  • 装置
  • 软体和服务
  • 全球免疫诊断市场（按技术、性能和预测）2019-2024 年、2024-2029 年、2034 年
  • 酵素免疫分析法
  • 化学冷光免疫检测
  • 萤光免疫分析法
  • 免疫检测
  • 快速检测
  • 其他技术
  • 全球免疫诊断试剂市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 感染疾病
  • 肿瘤学和内分泌学
  • 骨骼和矿物质疾病
  • 自体免疫疾病
  • 心臟生物标记
  • 药物监测
  • 其他用途
  • 全球免疫诊断市场：按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊所
  • 诊断实验室
  • 学术研究所
  • 其他最终用户
  • 全球免疫诊断试剂市场，依试剂及耗材类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 抗体
  • 检测试剂套件
  • 缓衝液和基材
  • 全球免疫诊断药物市场、仪器细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 免疫检测分析仪
  • 流式细胞仪
  • ELISA 酶标仪
  • 全球免疫诊断市场软体和服务细分，按类型、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 实验室资讯管理系统（LIMS）
  • 资料分析软体
  • 维护和支援服务

第七章 区域和国家分析

  • 全球免疫诊断市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球免疫诊断市场：依国家划分、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

  • 免疫诊断市场：竞争格局
  • 免疫诊断市场：公司简介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Arkray Inc. Overview, Products and Services, Strategy and Financial Analysis
    • bioMerieux Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Immunodiagnostic Systems Holdings Plc（IDS）Overview, Products and Services, Strategy and Financial Analysis
    • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • DiaSorin SpA
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson Services Inc.
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Qiagen NV
  • Tecan Trading AG
  • PerkinElmer Inc.
  • Merck KGaA
  • Becton Dickinson and Company
  • Grifols SA
  • Ortho Clinical Diagnostics
  • Beckman Coulter Inc.

第 32 章 全球市场竞争基准化分析与仪表板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年免疫诊断市场：提供新机会的国家
  • 2029 年免疫诊断市场：细分市场将带来新机会
  • 2029 年免疫诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第 36 章 附录

简介目录
Product Code: r24220

Immunodiagnostics is a diagnostic approach that relies primarily on the antigen-antibody response for detecting serum insulin. These tests are employed to identify antibodies and parasite antigens.

The principal products in the field of immunodiagnostics include reagents and consumables, instruments and software, and services. Reagents are substances used to initiate chemical reactions with other substances to detect the presence of specific substances, while consumables refer to traceable items utilized in the execution of analysis techniques. The technologies involved encompass enzyme-linked immunosorbent assay, chemiluminescence immunoassay, fluorescent immunoassay, radioimmunoassay, rapid tests, and others. These technologies find applications in various medical fields such as infectious diseases, oncology, endocrinology, bone and mineral diseases, autoimmunity disorders, cardiac biomarkers, drug monitoring, and more. The end-users of immunodiagnostics include hospitals, clinics, diagnostic laboratories, academic and research institutes, among others.

The immunodiagnostics market research report is one of a series of new reports from The Business Research Company that provides immunodiagnostics market statistics, including immunodiagnostics industry global market size, regional shares, competitors with immunodiagnostics market share, detailed immunodiagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the immunodiagnostics industry. This immunodiagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The immunodiagnostics market size has grown strongly in recent years. It will grow from$22.88 billion in 2024 to $24.54 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to the increasing incidence of infectious diseases, rise in autoimmune diseases, cancer diagnosis and monitoring, globalization of infectious diseases, public health initiatives, and screening programs

The immunodiagnostics market size is expected to see strong growth in the next few years. It will grow to $33.14 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to pandemic preparedness and response, personalized medicine and biomarker discovery, growing healthcare infrastructure in emerging markets, integration with laboratory information systems, rising burden of chronic diseases. Major trends in the forecast period include multiplexing technologies, point-of-care testing (POCT), biomarker discovery and personalized medicine, the rise of digital immunodiagnostics, shift toward liquid biopsy.

The rising prevalence of infectious diseases is anticipated to drive the growth of the immunodiagnostics market in the coming years. Infectious diseases are illnesses caused by germs such as viruses, bacteria, fungi, or parasites that can be transmitted between individuals. Immunodiagnostic assays are utilized to detect the presence of viruses in blood samples. For example, in March 2024, the Centers for Disease Control and Prevention (CDC), a U.S. government agency, reported that the number of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, representing an increase of 1,295 cases. Therefore, the growing prevalence of infectious diseases is expected to significantly boost the immunodiagnostics market.

The increasing healthcare expenditure is expected to propel the growth of the immunodiagnostics market in the future. Healthcare expenditure refers to the total spending on healthcare costs, encompassing all money spent on healthcare-related goods and services within a specific healthcare system or economy. This expenditure is vital for fostering the development and accessibility of immunodiagnostic solutions. For example, in November 2023, the Canadian Institute for Health Information, a non-profit organization based in Canada, projected that total health expenditure would reach $344 billion in 2023, indicating a modest growth of 2.8% compared to the previous year. Therefore, the rising healthcare expenditure is driving the expansion of the immunodiagnostics market.

Leading companies in the immunodiagnostics market are focused on creating innovative solutions, such as the S. pneumoniae antigen immunodiagnostic assay, to assist in diagnosing pneumococcal pneumonia infections. This assay is used to detect the presence of Streptococcus pneumoniae antigens in bodily fluids, facilitating the diagnosis of pneumococcal infections. For instance, in September 2024, DiaSorin S.p.A., an Italy-based biotechnology company, introduced the LIAISON S. pneumoniae antigen immunodiagnostic assay. This diagnostic test is specifically designed for the qualitative detection of Streptococcus pneumoniae antigens in urine samples from adults suspected of having pneumococcal pneumonia. The assay provides a high-throughput solution, enabling healthcare providers to rapidly diagnose and differentiate pneumococcal pneumonia from other respiratory infections. When utilized with LIAISON CLIA analyzers, the test delivers results in just 35 minutes, promoting timely and targeted antimicrobial therapy. Additionally, its capability to identify 91 serotypes enhances clinical decision-making and supports effective antibiotic stewardship, representing a significant advancement in the immunodiagnostics field for community-acquired pneumonia.

Major companies in the immunodiagnostics market are increasingly forming partnerships to drive revenues. Collaborations involving medical experts, academic entities, and IT firms can significantly contribute to market expansion by fostering innovation and accelerating clinical immunodiagnostics. For example, in October 2022, Telix Pharmaceuticals Limited, an Australia-based radiopharmaceutical company, partnered with GE Healthcare, a US-based medical technology company, to combine Telix's investigational PET imaging radiotracers with GE Healthcare's immuno-diagnostic range. This collaboration aims to improve therapy selection and patient monitoring in immunotherapy trials.

In May 2023, Freenome, a biotechnology company based in the U.S., acquired Oncimmune for an undisclosed amount. This acquisition is intended to enhance Freenome's capabilities in early cancer detection by incorporating Oncimmune's innovative technology and expertise in immune profiling. The move aims to strengthen Freenome's position in the oncology diagnostics market and expand its portfolio of liquid biopsy solutions. Oncimmune, located in the UK, specializes in developing technologies for immune profiling and biomarker discovery to aid in cancer diagnosis and monitoring.

Major companies operating in the immunodiagnostics market include Abbott Laboratories, Arkray Inc., bioMerieux Inc., Immunodiagnostic Systems Holdings Plc (IDS), Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Siemens AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Qiagen N.V., Tecan Trading AG, PerkinElmer Inc., Merck KGaA, Becton Dickinson and Company, Grifols S.A., Ortho Clinical Diagnostics, Beckman Coulter Inc., Bio-Techne Corporation, Creative Diagnostics, Fujirebio Holdings Inc., Gold Standard Diagnostics Corp., Hologic Inc., Luminex Corporation, Myriad Genetics Inc., Natera Inc., OraSure Technologies Inc., Quidel Corporation

North America was the largest region in the immunodiagnostics market in 2024. The regions covered in the immunodiagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the immunodiagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The immunodiagnostics market consists of revenues earned by entities by providing agglutination, nephelometry, immunoprecipitation, and radial immunodiffusion test services. The market value includes the value of related goods sold by the service provider or included within the service offering. The immunodiagnostics market also includes sales of anti-streptolysin-O latex, infectious mononucleosis slide, rheumatoid factor, and syphilis serology reagent. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunodiagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunodiagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunodiagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The immunodiagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Reagents And Consumables; Instruments; Software And Services
  • 2) By Technology: Enzyme-Linked Immunosorbent Assay; Chemiluminescence Immunoassay; Fluorescent Immunoassay; Radioimmunoassay; Rapid Test; Other Technologies
  • 3) By Application: Infectious Diseases; Oncology And Endocrinology; Bone And Mineral Diseases; Autoimmunity Disorders; Cardiac Biomarkers; Drug Monitoring; Other Applications
  • 4) By End User: Hospitals; Clinics; Diagnostic Laboratories; Academic And Research Institutes; Other End Users
  • Subsegments:
  • 1) By Reagents And Consumables: Antibodies; Assay Kits; Buffers And Substrates
  • 2) By Instruments: Immunoassay Analyzers; Flow Cytometers; ELISA Readers
  • 3) By Software And Services: Laboratory Information Management Systems (LIMS); Data Analysis Software; Maintenance And Support Services
  • Companies Mentioned: Abbott Laboratories; Arkray Inc.; bioMerieux Inc.; Immunodiagnostic Systems Holdings Plc (IDS); Bio-Rad Laboratories Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Immunodiagnostics Market Characteristics

3. Immunodiagnostics Market Trends And Strategies

4. Immunodiagnostics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Immunodiagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Immunodiagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Immunodiagnostics Market Growth Rate Analysis
  • 5.4. Global Immunodiagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Immunodiagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Immunodiagnostics Total Addressable Market (TAM)

6. Immunodiagnostics Market Segmentation

  • 6.1. Global Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents And Consumables
  • Instruments
  • Software And Services
  • 6.2. Global Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzyme-Linked Immunosorbent Assay
  • Chemiluminescence Immunoassay
  • Fluorescent Immunoassay
  • Radioimmunoassay
  • Rapid Test
  • Other Technologies
  • 6.3. Global Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Infectious Diseases
  • Oncology And Endocrinology
  • Bone And Mineral Diseases
  • Autoimmunity Disorders
  • Cardiac Biomarkers
  • Drug Monitoring
  • Other Applications
  • 6.4. Global Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Academic And Research Institutes
  • Other End Users
  • 6.5. Global Immunodiagnostics Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antibodies
  • Assay Kits
  • Buffers And Substrates
  • 6.6. Global Immunodiagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunoassay Analyzers
  • Flow Cytometers
  • ELISA Readers
  • 6.7. Global Immunodiagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Information Management Systems (LIMS)
  • Data Analysis Software
  • Maintenance And Support Services

7. Immunodiagnostics Market Regional And Country Analysis

  • 7.1. Global Immunodiagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Immunodiagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Immunodiagnostics Market

  • 8.1. Asia-Pacific Immunodiagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Immunodiagnostics Market

  • 9.1. China Immunodiagnostics Market Overview
  • 9.2. China Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Immunodiagnostics Market

  • 10.1. India Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Immunodiagnostics Market

  • 11.1. Japan Immunodiagnostics Market Overview
  • 11.2. Japan Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Immunodiagnostics Market

  • 12.1. Australia Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Immunodiagnostics Market

  • 13.1. Indonesia Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Immunodiagnostics Market

  • 14.1. South Korea Immunodiagnostics Market Overview
  • 14.2. South Korea Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Immunodiagnostics Market

  • 15.1. Western Europe Immunodiagnostics Market Overview
  • 15.2. Western Europe Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Immunodiagnostics Market

  • 16.1. UK Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Immunodiagnostics Market

  • 17.1. Germany Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Immunodiagnostics Market

  • 18.1. France Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Immunodiagnostics Market

  • 19.1. Italy Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Immunodiagnostics Market

  • 20.1. Spain Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Immunodiagnostics Market

  • 21.1. Eastern Europe Immunodiagnostics Market Overview
  • 21.2. Eastern Europe Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Immunodiagnostics Market

  • 22.1. Russia Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Immunodiagnostics Market

  • 23.1. North America Immunodiagnostics Market Overview
  • 23.2. North America Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Immunodiagnostics Market

  • 24.1. USA Immunodiagnostics Market Overview
  • 24.2. USA Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Immunodiagnostics Market

  • 25.1. Canada Immunodiagnostics Market Overview
  • 25.2. Canada Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Immunodiagnostics Market

  • 26.1. South America Immunodiagnostics Market Overview
  • 26.2. South America Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Immunodiagnostics Market

  • 27.1. Brazil Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Immunodiagnostics Market

  • 28.1. Middle East Immunodiagnostics Market Overview
  • 28.2. Middle East Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Immunodiagnostics Market

  • 29.1. Africa Immunodiagnostics Market Overview
  • 29.2. Africa Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Immunodiagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Immunodiagnostics Market Competitive Landscape
  • 30.2. Immunodiagnostics Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Arkray Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. bioMerieux Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Immunodiagnostic Systems Holdings Plc (IDS) Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Immunodiagnostics Market Other Major And Innovative Companies

  • 31.1. DiaSorin S.p.A.
  • 31.2. F. Hoffmann-La Roche Ltd.
  • 31.3. Johnson & Johnson Services Inc.
  • 31.4. Siemens AG
  • 31.5. Sysmex Corporation
  • 31.6. Thermo Fisher Scientific Inc.
  • 31.7. Danaher Corporation
  • 31.8. Qiagen N.V.
  • 31.9. Tecan Trading AG
  • 31.10. PerkinElmer Inc.
  • 31.11. Merck KGaA
  • 31.12. Becton Dickinson and Company
  • 31.13. Grifols S.A.
  • 31.14. Ortho Clinical Diagnostics
  • 31.15. Beckman Coulter Inc.

32. Global Immunodiagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Immunodiagnostics Market

34. Recent Developments In The Immunodiagnostics Market

35. Immunodiagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Immunodiagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Immunodiagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Immunodiagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer